Latest Regulatory News

Artrya Limited announces a strategic leadership reshuffle with co-founder John Konstantopoulos stepping into the CEO role as the company prepares for its U.S. commercial launch of the Salix® AI-powered platform.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

Aldoro Resources has reported significant assay results confirming a substantial northward extension of mineralisation at its Kameelburg Niobium and Rare Earth Elements deposit. The company is also expanding its drilling program and acquiring new rigs to deepen exploration.

Harvest Technology Group has raised $500,000 through unsecured convertible notes with a 15% annual interest rate, supporting its strategic three-year profit plan. The notes include attached options exercisable over two years, pending shareholder approval.

Copper Search Limited has secured two key exploration licences in South Australia's Eromanga Basin for Heavy Mineral Sands, setting the stage for a fully funded drilling campaign later this year. The company is also progressing copper-gold projects in New South Wales with government co-funding applications underway.

Jindalee Lithium has appointed Ian Rodger as Managing Director, marking a leadership milestone as the company advances its McDermitt Lithium Project. Rodger’s promotion follows his pivotal role in delivering key project studies and securing regulatory milestones.

Santana Minerals has unveiled an updated Pre-Feasibility Study for its Bendigo-Ophir Gold Project, revealing lower capital costs, higher gold grades, and robust financial returns that position the project as a low-cost, high-margin operation in New Zealand.

Paradigm Biopharmaceuticals has locked in a $27 million USD convertible note facility to fully fund its pivotal Phase 3 trial for knee osteoarthritis, ensuring operational momentum through key clinical milestones.

BlackRock Investment Management (Australia) Limited has announced the final confirmed cash distributions for nine Australian domiciled iShares ETFs, outlining key dates and investor requirements.

Proteomics International, alongside key partners, is investing $6 million to expand the WA Proteomics Facility, aiming to establish a nationally accredited platform for industrial-scale protein biomarker analysis in medicine and agriculture.

Next Science Limited has agreed to sell most of its assets to Demetra Holdings for US$50 million, with plans to return an estimated US$30 million net proceeds to shareholders pending approval.

Laramide Resources has announced a $10 million private placement to fund critical US permitting and corporate activities, with major shareholder Boss Energy backing the raise.